Kinetic Mechanism of Enterococcal Aminoglycoside Phosphotransferase 2‘ ‘-Ib

Authors:

Abstract
The major mechanism of resistance to aminoglycosides in clinical bacterial isolates is the covalent modification of these antibiotics by enzymes produced by the bacteria. Aminoglycoside 2‘ ‘-Ib phosphotransferase [APH(2‘ ‘)-Ib] produces resistance to several clinically important aminoglycosides in both Gram-positive and Gram-negative bacteria. Nuclear magnetic resonance analysis of the product of kanamycin A phosphorylation revealed that modification occurs at the 2‘ ‘-hydroxyl of the aminoglycoside. APH(2‘ ‘)-Ib phosphorylates 4,6-disubstituted aminoglycosides with kcat/Km values of 105−107 M-1 s-1, while 4,5-disubstituted antibiotics are not substrates for the enzyme. Initial velocity studies demonstrate that APH(2‘ ‘)-Ib operates by a sequential mechanism. Product and dead-end inhibition patterns indicate that binding of aminoglycoside antibiotic and ATP occurs in a random manner. These data, together with the results of solvent isotope and viscosity effect studies, demonstrate that APH(2‘ ‘)-Ib follows the random Bi−Bi kinetic mechanism and substrate binding and/or product release could limit the rate of reaction.
Keywords

This publication has 8 references indexed in Scilit: